References
- AgostiR. Migraine burden of disease: from the patient's experience to a socio-economic view. Headache58(Suppl. 1), 17–32 (2018).
- SprengerT, GoadsbyPJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med.7, 71 (2009).
- MoskowitzMA, BuzziMG, SakasDE, LinnikMD. Pain mechanisms underlying vascular headaches. Progress report 1989. Rev. Neurol. (Paris)145(3), 181–193 (1989).
- NosedaR, BursteinR. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain154(Suppl.1), S44–S53 (2013).
- GoadsbyPJ. Pathophysiology of migraine. Ann. Indian Acad. Neurol.15(Suppl. 1), S15–S22 (2012).
- PringsheimT, DavenportW, MackieGet al.Canadian Headache Society guideline for migraine prophylaxis. Can. J. Neurol. Sci.39(2 Suppl. 2), S1–S59 (2012).
- PompiliM, SerafiniG, InnamoratiMet al.Patient outcome in migraine prophylaxis: the role of psychopharmacological agents. Patient Relat. Outcome Meas.1, 107–118 (2010).
- LindeK, RossnagelK. Propranolol for migraine prophylaxis. Cochrane Database Syst. Rev. (2), CD003225 (2004).
- al-QassabHK, FindleyLJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Cephalalgia13(2), 128–131 (1993).
- JacksonJL, KuriyamaA, KuwatsukaYet al.Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis. PLoS ONE14(3), e0212785 (2019).
- AntoniadesC, BakogiannisC, LeesonPet al.Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circ.124(3), 335–345 (2011).
- Forero-PeñaDA, GutierrezFR. Statins as modulators of regulatory T-cell biology. Mediators Inflamm.167086 (2013).
- LiaoJK, LaufsU. Pleiotropic effects of statins. Ann. Rev. Pharmacol. Toxicol.45, 89–118 (2005).
- MillarPJ, FlorasJS. Statins and the autonomic nervous system. Clin. Sci.126(6), 401–415 (2014).
- BuettnerC, NirRR, BertischSMet al.Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial. Ann. Neurol.78(6), 970–981 (2015).
- LiberopoulosEN, MikhailidisDP. Could statins be useful in the treatment of patients with migraine?Headache46(4), 672–675 (2006).
- HesamiO, SistanizadM, AsadollahzadeE, JohariMS, Beladi-MoghadamN, Mazhabdar-GhashghaiH. Comparing the effects of atorvastatin with sodium valproate (divalproex) on frequency and intensity of frequent migraine headaches: a double-blind randomized controlled study. Clin. Neuropharmacol.41(3), 94–97 (2018).
- YinZ, FangY, RenLet al.Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine. Neurosci. Lett.465(1), 61–65 (2009).
- Al-KaragholiMA, HansenJM, GuoS, OlesenJ, AshinaM. Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain142(9), 2644–2654 (2019).
- LevinM. The international classification of headache disorders, (ICHD III) – changes and challenges. Headache53(8), 1383–1395 (2013).
- KurthT, WinterAC, EliassenAHet al.Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ353, i2610 (2016).
- KernickD. Statins for all: should patients who have migraine with aura be on a statin?Br. J. Gen. Pract.65(640), 571–572 (2015).
- MahmoudAN, MentiasA, ElgendyAYet al.Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1152407 subjects. BMJ Open8(3), e020498 (2018).
- BuettnerC, BursteinR. Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study. Cephalalgia35(9), 757–766 (2015).
- NewmanCB, PreissD, TobertJAet al.Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arterioscler. Thromb. Vasc. Biol.39(2), e38–e81 (2019).
- SrinivasanAV. Propranolol: a 50-year historical perspective. Ann. Indian Acad. Neurol.22(1), 21–26 (2019).
- ErtugrulDT, YavuzB, CilHet al.STATIN-D study: comparison of the influences of rosuvastatin and fluvastatin treatment on the levels of 25 hydroxyvitamin D. Cardiovasc. Therap.29(2), 146–152 (2011).
- AltunI, OzF, ArkayaSCet al.Effect of statins on endothelial function in patients with acute coronary syndrome: a prospective study using adhesion molecules and flow-mediated dilatation. J. Clin. Med. Res.6(5), 354–361 (2014).